摘要
目的评价术前同步推量调强放射治疗(sIBIMRT)技术应用于四肢软组织肉瘤(STS)外科边界中的临床疗效。方法将SIB-IMRT技术应用于32例局部晚期肢体STs患者的外科边界中。处方剂量:计划靶区(PTV)DT42.0~45.0Gy(15f,3周)全程同步推量外科边界靶区(GTVs)DT45.0~52.5Gy(15f,3周),5~7野;放疗结束后3~6周手术。测量SIB-IMRT前、后肢体周径及肿瘤大小;根据CTCAE4.0标准评价急性放射性皮肤损伤情况。结果SIB-IMRT前、后患肢肢体周径分别为(52.84±18.84)、(50.53±18.56)cm,周径平均缩小(2.31±1.98)cm,差异有统计学意义(P〈0.05);SI/3-IMRT反应率为81.3%(26/32),SIB-IMRT后部分缓解(PR)14例,病灶稳定(SD)18例;随访12~36个月,4例肺转移,5例死亡,4例复发,无复发中位生存时间为15个月;急性放射性皮肤损伤1级26例,2级4例,3级2例。结论SIB-IMRT技术应用于局部晚期的四肢STS外科边界近期疗效确切,可缩短放疗疗程,患者耐受性较好。
Objective To evaluate the clinical effect of simultaneous integrated boost intensity modulated radiation therapy (SIB-IMRT) for making limb soft tissue sarcoma(STS) surgical margin. Methods Totally 32 patients with locally advanced limb soft tissue sarcoma were performed surgical margin making the by SIB-IMRT. The prescription dose:PTV DT 42.0-45.0 Gy(15 f,3 weeks) ,SIB-GTVs DT 45.0-52.5 Gy(15 f,3 weeks) ,5-7 fields;the operation was performed at 3-6 weeks after SIB-IMRT. To measure the limb circumference and tumor size; to evaluate the acute radioactive skin damage by CTCAE 4.0. Results The limb circumferences were (52.84±18.84)cm and (50. 53 ± 18. 56)cm before and after SIB-IMRT, the circumference was averagely shrunk by (2.31±1.98)cm, the difference was statistically significant(P〈0.05);the SIB-IMRT response rate was 81. 3% (26/ 32), the partial remission (PR) was in 14 cases and stable disease(SD) was in 18 cases after SIB-IMRT;follow up lasted for 15-36 months,4 cases had pulmonary metastasis, 5 cases died and 4 cases had recurrence, the relapse-free median survival time was 15 months ;acute radioactive skin damage was grade 1 in 26 cases, grade 2 in 4 cases and grade 3 in 2 cases, Conclusion The short time effect of the SIB-IMRT technology for making locally advanced limb STS surgical margin is definite, can shorten the radiotherapeutic course with good patient's tolerance.
出处
《重庆医学》
CAS
北大核心
2016年第13期1776-1778,1781,共4页
Chongqing medicine
基金
新疆维吾尔自治区自然科学基金资助项目(2012211B15)
关键词
同步推量调强放疗
软组织肉瘤
外科边界
放射疗法
治疗结果
simultaneous integrated boost intensity modulated radiation therapy
soft tissue sarcoma
surgical margin
radiotherapy
treatment outcome